Opioid antagonist
Top View
- Coadministration of an Opioid Agonist and Antagonist for Pain Control
- Truncated Mu Opioid Receptor Splice Variants As Targets for Powerful Pain Relief with Reduced Side Effects
- Asymptomatic Celiac Disease Leo Pruimboom1,2* and Karin De Punder1,3
- Antagonists in the Medical Management of Opioid Use Disorders: Historical and Existing Treatment Strategies
- United States Patent (10) Patent No.: US 9,650,338 B1 Martirosyan (45) Date of Patent: May 16, 2017
- 2019 -- S 0409 Substitute a State of Rhode Island
- Mitragynine/Corynantheidine Pseudoindoxyls As Opioid Analgesics with Mu Agonism and Delta Antagonism Which Do Not Recruit
- Antinociceptive Action of Isolated Mitragynine from Mitragyna Speciosa Through Activation of Opioid Receptor System
- Delta-Opioid Receptor
- Guidelines for the Psychosocially Assisted Pharmacological Treatment
- BUPRENORPHINE for Opioid Use Disorder
- Embossable and Writable Multilaminate Backing
- Preventing Opioid Overdose Deaths with Take-Home Naloxone
- United States Patent (19) 11 Patent Number: 5,866,164 Kuczynski Et Al
- National Practice Guideline
- 2018 Evidence-Based Strategies for Preventing Opioid Overdose
- House of Representatives Staff Analysis Bill #: Cs/Hb
- Undesignated Opioid Antagonist Report, School Year 2019-20